[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.173.253. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Correspondence
August 18, 2008

Lack of Evidence for Adrenal Insufficiency After Single-Dose Etomidate

Arch Surg. 2008;143(8):808-809. doi:10.1001/archsurg.143.8.808-c

We found the retrospective review by Cotton et al1 regarding single-dose etomidate use and adrenal suppression concerning. However, we question the internal validity of the study design and caution against indicting single-dose etomidate in the airway management of trauma patients.

First, there is obvious selection bias in studying only patients in whom the clinicians suspected adrenal insufficiency (AI). Of approximately 2700 patients admitted to the trauma intensive care unit during the study period, only 198 (7%) underwent a cosyntropin stimulation test; 137 (5%) patients were eligible for analysis.

First Page Preview View Large
First page PDF preview
First page PDF preview
×